In immunization with Plasmodium falciparum apical membrane antigen 1, the specificity of antibodies depends on the species immunized.
about
Acquired immunity to malariaTransgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1Generation of humoral immune responses to multi-allele PfAMA1 vaccines; effect of adjuvant and number of component alleles on the breadth of responseHumoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity.Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responsesIn vitro growth-inhibitory activity and malaria risk in a cohort study in maliNew candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1Use of immunodampening to overcome diversity in the malarial vaccine candidate apical membrane antigen 1.Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.Analysis of the conformation and function of the Plasmodium falciparum merozoite proteins MTRAP and PTRAMPCan growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy?Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders.Overcoming allelic specificity by immunization with five allelic forms of Plasmodium falciparum apical membrane antigen 1.Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children.Mixed allele malaria vaccines: host protection and within-host selection.Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assay.Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccination.Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria.Variations in the quality of malaria-specific antibodies with transmission intensity in a seasonal malaria transmission area of Northern Ghana.
P2860
Q24651173-A88D813E-1B34-4692-AF3D-B1F2E385F648Q28743564-6A149525-A6A6-416F-A790-91CE06C9F1E9Q28748610-E8B30F7C-CB3A-4629-83B3-655A406AC771Q30942598-48858DC4-4BDA-4E9F-877D-44FFBAD5C6BDQ33356029-35EE7371-90A4-46BE-B649-8AFF98D92417Q33613892-39E2E861-AAC7-48B2-B56C-5053B5E49323Q34290768-072205CD-83AF-45A7-93EC-F90B9008596CQ34596157-3278CBD9-6D12-4FDF-86C9-DFE4563AC3DDQ35079832-58D5F4A2-8F4A-4A88-BFB4-A2D2E0747D2FQ35941001-5839EF93-DC39-43A9-BA91-7AB2F14C920CQ36391845-E3F5C801-433B-45E9-887E-1A2CE3B0E110Q36718066-815C3F38-D908-4930-B1A2-3BD37CA02DC6Q36826951-F5EDC362-E082-431F-B6D0-FF173DE3FF6BQ36862490-BB96CAF5-EA0B-4525-991D-EAFC217991D6Q37172956-6963D8D5-B46B-4CB6-B9F1-1262D30B906EQ37256085-17D34D1F-E319-42B1-9DCF-F81C30799449Q37459461-72F0B4B7-3A1E-4BE1-837B-7BB5C8A36BBFQ37582331-181E26D8-3D8E-47A3-9AFB-43DAA0112230Q41994486-152267C8-B6FC-492F-AF15-64EF7111673D
P2860
In immunization with Plasmodium falciparum apical membrane antigen 1, the specificity of antibodies depends on the species immunized.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
In immunization with Plasmodiu ...... ends on the species immunized.
@ast
In immunization with Plasmodiu ...... ends on the species immunized.
@en
type
label
In immunization with Plasmodiu ...... ends on the species immunized.
@ast
In immunization with Plasmodiu ...... ends on the species immunized.
@en
prefLabel
In immunization with Plasmodiu ...... ends on the species immunized.
@ast
In immunization with Plasmodiu ...... ends on the species immunized.
@en
P2093
P2860
P50
P356
P1476
In immunization with Plasmodiu ...... ends on the species immunized.
@en
P2093
Andrew C Orcutt
Birgitte Giersing
Olga V Muratova
P2860
P304
P356
10.1128/IAI.00593-07
P407
P577
2007-10-08T00:00:00Z